Can Testosterone Therapy Lower Prostate Cancer Risk?
In a study, investigators observed a reduced probability of prostate cancer in nondiabetic men with greater use of testosterone therapy.
In a study, investigators observed a reduced probability of prostate cancer in nondiabetic men with greater use of testosterone therapy.
New review identifies benefits of sodium-glucose co-transporter-2 (SGLT2) inhibitors at almost all levels of kidney function.
The first HIF-PHI, roxadustat, was recently approved in China.
Measuring health-related quality of life should be routine patient care, according to a new review.
In a study, Japanese men who ate mushrooms each week had lower risk for prostate cancer.
Recent review says findings from the PIVOTAL trial should allay concerns about the use of intravenous iron therapy in patients with end-stage renal disease suffering from anemia.
Renal & Urology News interviewed Michael Crane, MD, MPH, director of the WTC Health Program at Mount Sinai hospital about cancers and other long-term health problems linked with the events of September 11, 2001.
In a study of chronic kidney disease patients undergoing vascular access surgery for hemodialysis, severe preoperative anemia was associated with worse outcomes.
In a study of radical prostatectomy patients with Gleason score 7 prostate cancer, the risk for biochemical recurrence more than doubled in the presence of tertiary pattern 5 disease.
In a study, select CRPC patients who benefited from initial radium‐223 therapy but later had bone progression were re-challenged with additional radium-223 injections and had no serious adverse effects.